Prospective Clinical Performance Evaluation of the In-Vitro Diagnostics Medical Device MaGIA IBC for the CombIned screENing of HIV, Hepatitis B and Hepatitis C — Stella
Prospective Clinical Performance Evaluation of the In-Vitro Diagnostics Medical Device MaGIA IBC for the CombIned screENing of HIV, Hepatitis B and Hepatitis C
Not a traditional drug trial — this study doesn't follow the standard phase structure.
Trial locations(2 sites)
France
Hopital Européen de Marseille, Marseille, France
Centre Hospitalier de Perpignan - Equipe Mobile Hépatites, Perpignan